Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting tags : Biotechnology save search
Tryp Therapeutics Announces 99.92% Votes Cast by Shareholders in Favor of Arrangement Agreement at Annual General and Special Meeting of Securityholders, and Receipt of Final Order
Published: 2024-03-12 (Crawled : 11:00) - biospace.com/
CYBN | $0.3604 -1.99% 2.41% 2.2M
|
n/a
|
| O: -5.59%
H: 18.53%
C: 16.8%
meeting order therapeutics agreement
Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023: The 9th Joint ECTRIMS-ACTRIMS Meeting
Published: 2023-10-11 (Crawled : 11:00) - biospace.com/
IMUX | $1.23 4.24% 3.28% 170K
|
Health Technology
|
| O: 1.46%
H: 5.04%
C: 1.44%
sclerosis meeting trial
Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
Published: 2023-09-27 (Crawled : 14:00) - biospace.com/
ACET | News | $2.0 2.56% 2.5% 260K
|
Health Technology
|
| O: 0.7%
H: 4.86%
C: 0.0%
cancer cell immunotherapy meeting platform
Tyra Biosciences Announces Oral Presentations on TYRA-300 for Achondroplasia at the ASBMR and ASHG 2023 Annual Meetings
Published: 2023-09-21 (Crawled : 15:30) - biospace.com/
TYRA | $15.5 3.47% 3.48% 68K
|
Health Technology
|
| O: -0.72%
H: 1.52%
C: 0.36%
tyra-300 achondroplasia
MustGrow Biologics Corp. Announces Results of Shareholder Meeting
Published: 2023-06-30 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.46%
H: 0.66%
C: 0.4%
meeting results
Satellos Bioscience Announces Results from Its Annual General Meeting of Shareholders and Adoption of Amendments to Stock Option Plan
Published: 2023-06-30 (Crawled : 17:00) - biospace.com/
MSCLF | $0.3598 -3.02% 18.14% 15K
|
n/a
|
| O: 0.0%
H: 11.35%
C: 3.05%
bioscience meeting results
Can-Fite to Participate in Out-licensing and Distribution Partnering Meetings at Bio International Convention in Boston
Published: 2023-06-02 (Crawled : 12:00) - biospace.com/
CANF | $1.98 0.0% 8.7K
|
Health Technology
|
| O: 1.12%
H: 9.59%
C: 2.95%
distribution international
Convergent Therapeutics to Announce Clinical Trial Updates on its Lead Candidate at the American Society of Clinical Oncology (ASCO) Annual Meeting 2023
Published: 2023-05-25 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 77
|
Health Technology
|
| O: -2.0%
H: 0.0%
C: 0.0%
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
|
| O: -1.59%
H: 0.0%
C: 0.0%
candidate meeting trial therapeutics
OncoSec is encouraged after FDA meeting to discuss proposed neoadjuvant melanoma clinical program
Published: 2023-05-16 (Crawled : 15:20) - biospace.com/
ONCS | $0.2772 25.59% 52M
|
Health Services
|
| O: 3.9%
H: 54.12%
C: -35.35%
fda melanoma meeting program
Legend Biotech to Demonstrate Progress in Advancing Potential Treatment Options for Patients with Multiple Myeloma at ASCO and EHA Annual Meetings
Published: 2023-05-16 (Crawled : 13:20) - biospace.com/
LEGN | News | $47.06 1.88% 1.87% 760K
|
Health Technology
|
| O: -0.49%
H: 0.14%
C: -0.04%
biotech asco treatment potential
Nascent Biotech to Present Phase I Clinical Data at American Society of Clinical Oncology Annual Meeting
Published: 2023-05-09 (Crawled : 13:20) - biospace.com/
NBIO | $0.0898 -4.06% 15.32% 190K
|
|
| O: -6.0%
H: 12.55%
C: 12.55%
biotech meeting
Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA) to be Presented at the 2023 ASGCT Annual Meeting
Published: 2023-05-03 (Crawled : 00:00) - biospace.com/
MRNA | News S | $104.46 3.01% 2.94% 2.6M
|
Health Technology
|
| O: -0.67%
H: 1.81%
C: -0.29%
rna-3927 mrna meeting therapy
ContraFect Data Presentations at the 33rd Annual ECCMID Meeting Highlight the Potential Efficacy of Lysin CF-370 Against Antibiotic Resistant Gram-negative Pathogens
Published: 2023-04-20 (Crawled : 13:20) - biospace.com/
CFRX | $0.05 0.0% 910K
|
Health Technology
|
| O: 16.48%
H: 24.81%
C: -2.93%
cf-370 meeting pathogens potential
Infinity Pharmaceuticals Announces Two Upcoming Presentations on PI3K-γ and Eganelisib by Dr. Judith Varner at the 2023 Annual Meeting of the American Association of Cancer Research
Published: 2023-04-13 (Crawled : 22:00) - biospace.com/
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: 3.59%
H: 8.77%
C: 2.72%
association cancer pharmaceuticals research meeting
Turnstone Biologics to Present Preclinical Data for Selected TIL Therapy at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Published: 2023-04-13 (Crawled : 12:00) - biospace.com/
FNCTF | News | $11.16 1.13% -20.84% 130
|
Communications
| Email alert
Add to watchlist
association cancer research preclinical meeting therapy
Kiora Announces the Acceptance of Late-Breaking Abstract on Phase 1b Study of KIO-301 in Retinitis Pigmentosa at The American Society of Neuroradiology 2023 Meeting
Published: 2023-03-30 (Crawled : 17:00) - biospace.com/
KPRX | $0.485 -1.08% -1.07% 97K
|
Manufacturing
|
| O: -1.44%
H: 2.78%
C: 0.29%
kio-301 meeting study
Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
Published: 2023-03-02 (Crawled : 14:00) - biospace.com/
ANIX | $3.01 -3.53% -2.63% 58K
|
Health Technology
|
| O: 0.92%
H: 0.6%
C: -5.85%
meeting update
Tiziana Life Sciences Announces Date of Annual General Meeting 2022
Published: 2022-12-06 (Crawled : 13:20) - biospace.com/
TLSA | News | $0.7536 13.15% 11.2% 540K
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: -4.69%
sciences meeting life
GenFleet Therapeutics to Present Data from Phase I Trial of GFH009 Monotherapy at the 2022 Annual Meeting of American Society of Hematology (ASH)
Published: 2022-11-28 (Crawled : 13:00) - biospace.com/
SLS | $1.54 0.0% 1.5M
|
Health Technology
|
| O: 1.26%
H: 2.07%
C: -4.56%
gfh009 meeting trial therapeutics
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
Published: 2022-11-11 (Crawled : 21:00) - biospace.com/
IMCR | $55.82 0.25% 0.17% 300K
|
Manufacturing
|
| O: -0.02%
H: 7.97%
C: 6.73%
melanoma meeting biomarker kimmtrak
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.